文献速递神经肿瘤

立体定向放射外科与主动监测治疗无症状颅底脑膜瘤:一项国际多中心匹配队列研究

Stereotactic radiosurgery versus active surveillance for asymptomatic, skull-based meningiomas: an international, multicenter matched cohort study.
PubMed 文献 · J Neurooncol · 2022-01-24

这项回顾性多中心匹配队列研究比较了无症状颅底脑膜瘤患者接受 upfront 立体定向放射外科(SRS)或主动监测的影像与临床结局。在按年龄、肿瘤体积和随访时间进行倾向评分匹配后,每组各110例。SRS组肿瘤控制率为98.2%,主动监测组为61.8%,SRS与更优的局部肿瘤控制相关(p < 0.001,HR = 0.01,95% CI = 0.002-0.13)。SRS组3例(2.7%)和主动监测组6例(5.5%)出现神经功能恶化,分别有1例(0.9%)和11例(10%)需要手术处理。作者认为SRS应作为主动监测的替代方案用于无症状颅底脑膜瘤的初始管理,并建议若选择主动监测,在发现影像学肿瘤进展时、临床进展前推荐SRS。

要点

  • 匹配后每组110例,SRS组肿瘤控制率98.2%,主动监测组61.8%。
  • SRS与更优局部肿瘤控制相关(p < 0.001,HR = 0.01,95% CI = 0.002-0.13)。
  • 作者建议SRS可作为无症状颅底脑膜瘤初始管理的主动监测替代方案。

核心结论

  • SRS与无症状颅底脑膜瘤更优的局部控制相关,且发病率低;SRS应作为主动监测的替代方案用于初始管理。
  • 若选择主动监测,作者建议在发现影像学肿瘤进展时、临床进展前推荐SRS。

研究设计与样本

  • 回顾性、多中心研究,纳入无症状颅底脑膜瘤患者。
  • 未匹配队列共417例;按年龄、肿瘤体积和随访时间进行倾向评分匹配后,每组各110例。
  • 研究终点包括局部肿瘤控制和新发归因于肿瘤的神经功能缺损。

主要发现

  • SRS组肿瘤控制率为98.2%,主动监测组为61.8%。
  • SRS与更优的局部肿瘤控制相关(p < 0.001,HR = 0.01,95% CI = 0.002-0.13)。
  • SRS组3例(2.7%)和主动监测组6例(5.5%)出现神经功能恶化。
  • SRS组1例(0.9%)和主动监测组11例(10%)在随访期间需要手术处理脑膜瘤。

临床怎么用

  • 作者认为SRS应作为主动监测的替代方案用于无症状颅底脑膜瘤的初始管理。
  • 作者建议若选择主动监测,在发现影像学肿瘤进展时、临床进展前推荐SRS。
  • 原文未据此给出其他推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The optimal management of asymptomatic, skull-based meningiomas is not well defined. The aim of this study is to compare the imaging and clinical outcomes of patients with asymptomatic, skull-based meningiomas managed either with upfront stereotactic radiosurgery (SRS) or active surveillance. METHODS: This retrospective, multicenter study involved patients with asymptomatic, skull-based meningiomas. The study end-points included local tumor control and the development of new neurological deficits attributable to the tumor. Factors associated with tumor progression and neurological morbidity were also analyzed. RESULTS: The combined unmatched cohort included 417 patients. Following propensity score matching for age, tumor volume, and follow-up 110 patients remained in each cohort. Tumor control was achieved in 98.2% and 61.8% of the SRS and active surveillance cohorts, respectively. SRS was associated with superior local tumor control (p < 0.001, HR = 0.01, 95% CI = 0.002-0.13) compared to active surveillance. Three patients (2.7%) in the SRS cohort and six (5.5%) in the active surveillance cohort exhibited neurological deterioration. One (0.9%) patient in the SRS-treated and 11 (10%) patients in the active surveillance cohort required surgical management of their meningioma during follow-up. CONCLUSIONS: SRS is associated with superior local control of asymptomatic, skull-based meningiomas as compared to active surveillance and does so with low morbidity rates. SRS should be offered as an alternative to active surveillance as the initial management of asymptomatic skull base meningiomas. Active surveillance policies do not currently specify the optimal time to intervention when meningioma growth is noted. Our results indicate that if active surveillance is the initial management of choice, SRS should be recommended when radiologic tumor progression is noted and prior to clinical progression.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Mantziaris G, Pikis S, Samanci Y, et al. Stereotactic radiosurgery versus active surveillance for asymptomatic, skull-based meningiomas: an international, multicenter matched cohort study. J Neurooncol. 2022. PMID: 35067846. doi:10.1007/s11060-021-03923-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。